Koninklijke Philips NV

Koninklijke Philips NV maintains a capital structure characterized by significant leverage, with long-term debt of €7.81 billion against total equity of €10.96 billion, resulting in a debt-to-equity ratio of 0.71. The company holds €2.79 billion in cash and equivalents, which is insufficient to cover total debt, leading to a negative net cash position. Liquidity is assessed as medium, supported by a current ratio of 1.32, indicating adequate short-term asset coverage for liabilities. The market capitalization stands at €22.75 billion, with a price-to-book ratio of 2.08 and an EV/EBITDA of 18.38, reflecting a valuation that accounts for its debt load.

Profitability metrics show a return on equity of 8.83% and a return on assets of 3.59%, based on net income of €895 million and total assets of €26.94 billion. The company generated €17.83 billion in revenue, with a gross profit of €8.06 billion and operating income of €1.42 billion. These returns are derived from a business model that requires substantial asset bases, as evidenced by the total assets figure. The operating margin is approximately 8%, indicating moderate efficiency in converting revenue to operating profit before interest and taxes.

Revenue concentration and segment details are not explicitly provided in the available data, preventing a detailed analysis of geographic or product-specific exposure. The company's activity is broadly classified as pharmaceuticals, but without specific segment breakdowns, the revenue mix remains undefined in this analysis. The lack of segment data limits the ability to assess concentration risks or growth drivers within specific business units.

Growth trajectory analysis is constrained by the absence of historical period data in the input. Without five-year annual or eight-quarter quarterly revenue and net income figures, it is not possible to determine the trend in revenue growth or earnings stability. The current financial snapshot provides a static view of performance, but longitudinal trends required for growth assessment are missing.

Risk assessment indicates medium liquidity risk and low dilution risk. A key flag is the negative net cash position after subtracting total debt, which highlights reliance on debt financing. The dilution risk is low, as basic and diluted shares outstanding are identical at 951.29 million, suggesting no significant in-the-money options or convertible securities impacting share count. The company's risk profile is further influenced by its leverage and the need to manage debt obligations effectively.

Recent events and market sentiment are reflected in analyst estimates, with a mean price target of €28.32 and a median of €27.25, implying potential upside from the current market price of €23.92. The mean recommendation is 2.35, with 4 strong buys, 7 buys, and 12 holds, indicating a generally positive but cautious outlook from analysts. No specific filing, news, or transcript observations are provided to detail recent corporate actions or strategic shifts.

Koninklijke Philips NV (PHIA.AS) is undergoing its first analysis, meaning there is no prior basis for computing material changes in its financial or operational metrics. Consequently, the primary signal of activity comes from a major modification in shareholder holdings rather than a shift in fundamental performance indicators. A significant change was detected in the position of investor ID 587 as of March 31, 2026. The investor’s stake was recorded as increasing from 1,696 shares to 41,885 shares, representing a rise in value from $0.046 million to $1.148 million. This adjustment was detected on July 2, 2026. Conversely, a separate detection on July 1, 2026, recorded the same investor’s position as decreasing from 41,885 shares back to 1,696 shares. This conflicting data suggests a volatility or correction in the reporting of the investor’s weight, which shifted from 0.00066% to 0.000027% of the total holding. These holder changes are notable within the context of Koninklijke Philips NV’s broader structure, which includes 22 top holders and membership in one index. With no analyst coverage or officer changes reported, the focus remains on these specific institutional adjustments as the only recorded activity for this ticker.

Operating income surged 169.2% year-over-year to EUR 1.4 billion, signaling a robust operational turnaround.

Free cash flow jumped 331.6% to EUR 931 million, demonstrating significantly improved cash generation capabilities.

Analysts project 20.2% upside to a mean price target of EUR 28.65, reflecting strong market confidence.

Revenue declined 1.0% year-over-year to EUR 17.8 billion, indicating stagnating top-line growth momentum.

Debt-to-equity ratio of 0.71 sits in the bottom quartile of peers, signaling elevated financial leverage risk.

Long-term debt increased to EUR 7.8 billion, raising concerns about the company's growing debt burden.

Medium liquidity and credit risk flags suggest potential vulnerabilities in the company's financial stability.

Net income CAGR of -27.9% over four years reflects historically poor earnings performance trends.

Revenue €3.90B, −4,7% YoY; Operating income +56,5% YoY.

• ▍Revenue €3.90B, −4,7% YoY
• ▍Operating income +56,5% YoY
• ▍Net income +101,3% YoY
• ▍Free cash flow +29,2% YoY
• ▍Net margin 3.9%

Revenue €5.10B, +1,1% YoY; Operating income +170,0% YoY.

• ▍Revenue €5.10B, +1,1% YoY
• ▍Operating income +170,0% YoY
• ▍Net income +217,6% YoY
• ▍Net margin 7.7%

Revenue €4.30B, −1,7% YoY; Operating income −2,1% YoY.

• ▍Revenue €4.30B, −1,7% YoY
• ▍Operating income −2,1% YoY
• ▍Net income +1,1% YoY
• ▍Net margin 4.3%

Revenue €4.34B, −2,8% YoY; Operating income −51,0% YoY.

• ▍Revenue €4.34B, −2,8% YoY
• ▍Operating income −51,0% YoY
• ▍Net income −46,9% YoY
• ▍Net margin 5.5%

Revenue €4.10B; Operating income €154.0M.

• ▍Revenue €4.10B
• ▍Operating income €154.0M
• ▍Net margin 1.8%

Revenue €5.04B; Operating income €200.0M.

• ▍Revenue €5.04B
• ▍Operating income €200.0M
• ▍Net margin -6.6%

Revenue €4.38B; Operating income €337.0M.

• ▍Revenue €4.38B
• ▍Operating income €337.0M
• ▍Net margin 4.2%

Revenue €4.46B; Operating income €816.0M.

• ▍Revenue €4.46B
• ▍Operating income €816.0M
• ▍Net margin 10.1%

Revenue €17.83B, −1,0% YoY; Operating income +169,2% YoY.

• ▍Revenue €17.83B, −1,0% YoY
• ▍Operating income +169,2% YoY
• ▍Net income +227,7% YoY
• ▍Free cash flow +331,6% YoY
• ▍Net margin 5.0%

Revenue €18.02B, −0,8% YoY; Operating income +560,0% YoY.

• ▍Revenue €18.02B, −0,8% YoY
• ▍Operating income +560,0% YoY
• ▍Net income −50,8% YoY
• ▍Free cash flow −622,1% YoY
• ▍Net margin -3.9%

Revenue €18.17B, +1,9% YoY; Operating income +92,5% YoY.

• ▍Revenue €18.17B, +1,9% YoY
• ▍Operating income +92,5% YoY
• ▍Net income +71,1% YoY
• ▍Free cash flow +104,9% YoY
• ▍Net margin -2.6%

Revenue €17.83B, +3,9% YoY; Operating income −376,5% YoY.

• ▍Revenue €17.83B, +3,9% YoY
• ▍Operating income −376,5% YoY
• ▍Net income −148,4% YoY
• ▍Free cash flow −338,0% YoY
• ▍Net margin -9.0%